boosting glucose-dependent insulin secretion: These peptides raise insulin release with the pancreas, but only when blood sugar is elevated, decreasing the risk of hypoglycemia. Semaglutide imitates the steps of GLP 1 by stimulating insulin creation within the pancreatic beta cells, decreasing blood glucose degrees curbing hunger and slowing down